These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Perspectives on the amyloid cascade hypothesis of Alzheimer's disease]. Simón AM; Frechilla D; del Río J Rev Neurol; 2010 Jun; 50(11):667-75. PubMed ID: 20514639 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease. Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276 [TBL] [Abstract][Full Text] [Related]
10. Isoaspartate formation and neurodegeneration in Alzheimer's disease. Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409 [TBL] [Abstract][Full Text] [Related]
11. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Hardy J; Duff K; Hardy KG; Perez-Tur J; Hutton M Nat Neurosci; 1998 Sep; 1(5):355-8. PubMed ID: 10196523 [TBL] [Abstract][Full Text] [Related]
12. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506 [TBL] [Abstract][Full Text] [Related]
13. Pathways linking Abeta and tau pathologies. LaFerla FM Biochem Soc Trans; 2010 Aug; 38(4):993-5. PubMed ID: 20658991 [TBL] [Abstract][Full Text] [Related]
14. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies. Sorrentino G; Bonavita V Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468 [TBL] [Abstract][Full Text] [Related]
15. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J; Selkoe DJ Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773 [TBL] [Abstract][Full Text] [Related]
16. A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster. Finelli A; Kelkar A; Song HJ; Yang H; Konsolaki M Mol Cell Neurosci; 2004 Jul; 26(3):365-75. PubMed ID: 15234342 [TBL] [Abstract][Full Text] [Related]
17. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151 [TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau. Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643 [TBL] [Abstract][Full Text] [Related]
19. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice. Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]